Joint replacement surgeon Vinod Dasa, M.D., says there will be a heightened focus on eliminating waste and redundancies, especially in the “last mile” of the supply chain.
While the spine industry has focused on 3D printed cages, enabling technology and minimally invasive surgery, it has forgotten a critical priority: infection prevention, says Aakash Agarwal, Ph.D., Director of Research at Spinal Balance.
Robotic systems would have undoubtedly received major play at the Annual Meeting. We pulled together recent strategic activity to provide greater insight.
In moving to the provider side of orthopedics after spending decades in industry, Doug Leach has learned a valuable lesson: Partner with providers. Not just the surgeon.
Many of the lessons that Tom Afzal has applied throughout his career he learned while working at American Hospital Supply Corporation—one of the largest medical device companies in the ‘70s-‘80s—his first professional position after college. As part of a management path program, Mr. Afzal was required to work in many functional areas of the company—sales, marketing, finance, production, R&D, quality, etc.
Marty Altshuler and Rick Henson were given an opportunity to acquire spinal products and transition from distributorship to a full line implant manufacturing company. They made the deal and founded ChoiceSpine back in 2006.
The spine market’s evolving reimbursement landscape can be hard for device companies and surgeons to navigate. While at NASS, we asked reimbursement expert Kim Norton for a high-level view of the reimbursement shifts taking place today. Ms. Norton is Vice President of Reimbursement for Simplify Medical and serves as a consultant, including in reimbursement and payor relations for Aesculap.
Twenty-two private companies developing new and emerging technologies, including hardware, biologics, software and diagnostics, are expected to provide pitches at MNVC.
The growth of robotics, additive, outsourcing and mid-sized device companies and contract manufacturers are among the main narratives that we-like Mr. Madani-expect will shape industry dynamics in the coming years.
Ortho Spine Partners' business model is new to us. Using complementary perspectives from device company and hospital purchasing sides as a team approach, they serve as hired strategists and executors for product commercialization and corporate activities. Orthopedics is a relationship-driven industry, and the modern sales process requires different relationships. OSP's leadership is betting that its surgeon, hospital, sales rep and device company contacts, as well as its out-of-the-box thinking, can be leveraged to provide small partnering companies with national scale typically not attainable by young companies.